denalitherapeutics.com (DNLI) - Uzoq muddatli majburiyatlarning kapitalga nisbati
GURU.Markets platformasida Denali Therapeutics (DNLI) uchun moliyaviy narx vizualizatsiyasi aktivning narx harakatini namoyish etadi, uning qiymati iqtisodiy sikllarga bog'liq emas, balki dori-darmonlarni sinovdan o'tkazish bosqichlari bilan belgilanadi va ushbu ko'rsatkich 0.03 darajasida turibdi. Biznes ilmiy tadqiqotlarning barqarorligiga va sanoat gigantlari bilan hamkorlikka tayanadi. Kompaniyaga tegishli strategiya moddalarni miyaga tashish tizimini joriy etish va klinik sinovlarni kengaytirishga asoslangan.
&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_DNLI_-_Denali-Therapeutics_-_Long-Term-Debt-to-Equity-Ratio "DNLI - Denali Therapeutics Inc. Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 31.10.2026 oraligʻida | 👁️GURU.Markets👁️")
Denali Therapeutics (DNLI) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Denali Therapeutics|DNLI - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi denalitherapeutics.com|DNLI - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Denali Therapeutics Inc.|DNLI - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Denali Therapeutics|Tezkor likvidlik koeffitsiyenti denalitherapeutics.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning jamlanma tahlili:DNLI (Denali)
Qon-miya to'sig'ini kesib o'tuvchi noyob texnologiyani ishlab chiqish katta investitsiyalarni talab qiladi, bu esa Denali Therapeutics (DNLI) moliyaviy barqarorligini saqlab qolish uchun qarz yuklamasini nazorat qilishni muhim qiladi. Muddati bir yildan ortiq bo'lgan majburiyatlarning kapitalga nisbati kompaniyaning tashqi qarzlarga bog'liqligini o'lchaydi, uzoq muddatli qarzning kapitalga nisbati qiymati esa stagnatsiya xavfini yoki biznesning kengayish potentsialini real vaqt rejimida baholash imkonini beradi.
Raqobatdosh kompaniyalar tahlili
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|HRMY (Harmony Biosciences) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BHVN (biohavenpharma.com)|Uzoq muddatli qarzning kapitalga nisbati AMLX|TRVI - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Praxis Medicines PRAX|AVXL: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|CeriBell, Inc. - Uzoq muddatli qarzning kapitalga nisbati|PRTA - Uzoq muddatli qarzning kapitalga nisbati|alector.com (ALEC) - Uzoq muddatli qarzning o'z kapitaliga nisbati|ANNX (Annexon Biosciences) - Uzoq muddatli qarzning o'z kapitaliga nisbati|OMER (Omeros Corp) - Uzoq muddatli qarzning kapitalga nisbati|Neurogene Therapeutics (NGNE) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati ACIU (AC Immune)|VYGR (voyagertherapeutics.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Neumora Therapeutics, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati SCLX (Scilex Holding)|Tevogen Bio Holdings, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti ACOG (Alpha Cognition)|CGTX: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati inhibikase.com (IKT)|Uzoq muddatli qarzning o'z kapitaliga nisbati Cassava Sciences|ASRT: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati COYA|Uzoq muddatli qarzning kapitalga nisbati vistagen.com (VTGN)|Uzoq muddatli qarzning o'z kapitaliga nisbati Ovid Therapeutics OVID|ABOS (acumenpharm.com) - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|CervoMed - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Alterity Therapeutics|CLNN (clene.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|PepGen (PEPG) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati JUNS|RLMD (relmada.com) - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ANVS|Uzoq muddatli qarzdorlikning kapitalga nisbati gracetx.com|Uzoq muddatli qarzning kapitalga nisbati AIFF (Firefly Neuroscience Inc)|KLTO - Uzoq muddatli qarzning o'z kapitaliga nisbati|NRSN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati revivapharma.com RVPH|MTVA: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi NRXS|Uzoq muddatli qarzning o'z kapitaliga nisbati Helius Medical Technologies, Inc.|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi PASG (Passage Bio Corp)|Uzoq muddatli qarzning o'z kapitaliga nisbati Neuphoria Therapeutics Inc. (NEUP)|Uzoq muddatli qarzning o'z kapitaliga nisbati NERV (minervaneurosciences.com)|Uzoq muddatli qarzning kapitalga nisbati ATHA (Athira Pharma)|Uzoq muddatli qarzdorlikning kapitalga nisbati Addex Therapeutics Ltd. (ADXN)|ALZN - Uzoq muddatli qarzning o'z kapitaliga nisbati|CYCN (Cyclerion Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|PTIX: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Pasithea Therapeutics Corp. (KTTA)|Uzoq muddatli qarzning o'z kapitaliga nisbati CRGT|Uzoq muddatli qarzning kapitalga nisbati Avenue Therapeutics Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati Brainstorm Cell Therapeutics, Inc. (BCLI)|CARA (Cara Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Chromocell Therapeutics CHRO|Eliem Therapeutics, Inc. (ELYM) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Intra-Cellular - Uzoq muddatli qarzning kapitalga nisbati|LBPH (Longboard Pharmaceuticals Inc) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|MRNS: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati NKGen Biotech Corp (NKGN)|Uzoq muddatli qarzning o'z kapitaliga nisbati NeuroBo Pharmaceuticals|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi SAGE (sagerx.com)|Uzoq muddatli qarzning kapitalga nisbati SNPX|Uzoq muddatli qarzning kapitalga nisbati Trevena Inc. (TRVN)|Uzoq muddatli qarzning o'z kapitaliga nisbati Vigil Neuroscience, Inc. VIGL|Anew Medical Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Cerevel Therapeutics - Uzoq muddatli qarzning kapitalga nisbati